{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:22:37Z","timestamp":1790648557226,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T00:00:00Z","timestamp":1653696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T00:00:00Z","timestamp":1653696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"science and technology support project of Sichuan province","award":["2015SZ0234-3"],"award-info":[{"award-number":["2015SZ0234-3"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease, and the immune inflammatory response is thought to play an important role in pathogenesis. However, the immunophenotype of patients with COPD is unknown. Herein, we evaluated the immunophenotype of patients with acute exacerbation of COPD (AECOPD).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A cross-sectional study was conducted in West China Hospital from September 2018 to October 2019. The proportion of CD4\u2009+\u2009T lymphocyte subtypes (Th1, Th2, Th17 and Treg) and levels of serum cytokines in the peripheral blood of patients with AECOPD, stable COPD (SCOPD), healthy smokers (HSs)and healthy controls (HCs) were evaluated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 15 HCs, 19 HSs, 42 patients with SCOPD, and 55 patients with AECOPD were included. Compared to patients with SCOPD, Th1 cells, Th17 cells, Treg cell ratio, Th1\/Th2 cell ratio, and the levels of C-reactive protein, interleukin (IL)-6, and IL-10 were significantly increased in patients with AECOPD (P\u2009&lt;\u20090.001), while the proportion of Th2 cells was significantly reduced (P\u2009&lt;\u20090.01). The proportion of Th17 cells was positively correlated with COPD Assessment Test score (r\u2009=\u20090.266, P\u2009=\u20090.009), modified Medical Research Council dyspnea score (r\u2009=\u20090.858, P\u2009&lt;\u20090.0001), and Th1 cell ratio (r\u2009=\u20090.403, P\u2009&lt;\u20090.0001) and negatively correlated with forced vital capacity (r\u2009=\u2009\u2212\u00a00.367, P\u2009=\u20090.009) and proportion of Th2 cells (r\u2009=\u2009\u2212\u00a00.655, P\u2009&lt;\u20090.0001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The immunophenotype of patients with AECOPD shows abnormal activation of Th1, Th17, and Treg cells. There is a correlation between the proportion of Th17 cells and the severity of COPD; therefore, this may represent a novel index for the evaluation of COPD severity.<\/jats:p>\n                <jats:p><jats:italic>Trial registration:<\/jats:italic> China Clinical Trials Registry, ChiCTR1800018452, registered 19 September 2018, <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.chictr.org.cn\/index.aspx\">https:\/\/www.chictr.org.cn\/index.aspx<\/jats:ext-link>.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12931-022-02058-x","type":"journal-article","created":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T09:03:09Z","timestamp":1653728589000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Immunophenotype in acute exacerbation of chronic obstructive pulmonary disease: a cross-sectional study"],"prefix":"10.1186","volume":"23","author":[{"given":"Xiao-feng","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-xia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-li","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3805-8542","authenticated-orcid":false,"given":"De-yun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,28]]},"reference":[{"key":"2058_CR1","unstructured":"Global strategy for the diagnosis, management, and prevention of COPD (2020 update). http:\/\/www.goldcopd.org. Accessed 04 Nov 2019."},{"key":"2058_CR2","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1164\/rccm.200912-1843CC","volume":"182","author":"MK Han","year":"2010","unstructured":"Han MK, Agusti A, Calverley PM, Celli BR, Criner G, Curtis JL, Fabbri LM, Goldin JG, Jones PW, Macnee W, et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med. 2010;182:598\u2013604.","journal-title":"Am J Respir Crit Care Med"},{"key":"2058_CR3","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1080\/15412555.2017.1303041","volume":"14","author":"N Siafakas","year":"2017","unstructured":"Siafakas N, Corlateanu A, Fouka E. Phenotyping before starting treatment in COPD? COPD. 2017;14:367\u201374.","journal-title":"COPD"},{"key":"2058_CR4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12931-015-0208-4","volume":"16","author":"LM Pinto","year":"2015","unstructured":"Pinto LM, Alghamdi M, Benedetti A, Zaihra T, Landry T, Bourbeau J. Derivation and validation of clinical phenotypes for COPD: a systematic review. Respir Res. 2015;16:50.","journal-title":"Respir Res"},{"key":"2058_CR5","first-page":"83","volume":"20","author":"Y Chen","year":"2015","unstructured":"Chen Y, Zhan X, Zhang M. Study on the proportion of Th17 and Treg cells and the level of inflammatory factors in elderly patients with COPD at different stages. J Clin Exp Med. 2015;20:83\u20136.","journal-title":"J Clin Exp Med"},{"key":"2058_CR6","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.biopha.2018.09.113","volume":"108","author":"X Zheng","year":"2018","unstructured":"Zheng X, Zhang L, Chen J, Gu Y, Xu J, Ouyang Y. Dendritic cells and Th17\/Treg ratio play critical roles in pathogenic process of chronic obstructive pulmonary disease. Biomed Pharmacother. 2018;108:1141\u201351.","journal-title":"Biomed Pharmacother"},{"key":"2058_CR7","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/crj.12147","volume":"9","author":"H Wang","year":"2015","unstructured":"Wang H, Ying H, Wang S, Gu X, Weng Y, Peng W, Xia D, Yu W. Imbalance of peripheral blood Th17 and Treg responses in patients with chronic obstructive pulmonary disease. Clin Respir J. 2015;9:330\u201341.","journal-title":"Clin Respir J"},{"key":"2058_CR8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1365-3083.2010.02474.x","volume":"73","author":"J Domagala-Kulawik","year":"2011","unstructured":"Domagala-Kulawik J, Hoser G, Dabrowska M, Safianowska A, Chazan R. CD4+\/CD25+ cells in systemic inflammation in COPD. Scand J Immunol. 2011;73:59\u201365.","journal-title":"Scand J Immunol"},{"key":"2058_CR9","first-page":"351","volume":"67","author":"MF Ghany","year":"2018","unstructured":"Ghany MF, Makhlouf HA, Gaber N. Downregulation of regulatory T cells in patients with chronic obstructive pulmonary disease: relation to disease severity. Egypt J Chest Dis Tuberc. 2018;67:351.","journal-title":"Egypt J Chest Dis Tuberc"},{"key":"2058_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40413-016-0095-2","volume":"9","author":"A Chiappori","year":"2016","unstructured":"Chiappori A, Folli C, Balbi F, Caci E, Riccio AM, De Ferrari L, Melioli G, Braido F, Canonica GW. CD4(+)CD25(high)CD127(-) regulatory T-cells in COPD: smoke and drugs effect. World Allergy Organ J. 2016;9:5.","journal-title":"World Allergy Organ J"},{"key":"2058_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00220","author":"J-H Wu","year":"2019","unstructured":"Wu J-H, Zhou M, Jin Y, Meng Z-J, Xiong X-Z, Sun S-W, Miao S-Y, Han H-L, Tao X-N. Generation and immune regulation of CD4+CD25\u2212Foxp3+ T cells in chronic obstructive pulmonary disease. Front Immunol. 2019. https:\/\/doi.org\/10.3389\/fimmu.2019.00220.","journal-title":"Front Immunol"},{"key":"2058_CR12","first-page":"679","volume":"50","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Yan Q, Liu H. Expression of Treg in peripheral blood and lung tissue of patients with chronic obstructive pulmonary disease. Acta Univ Med Anhui. 2015;50:679\u201382.","journal-title":"Acta Univ Med Anhui"},{"key":"2058_CR13","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.immuni.2008.03.004","volume":"28","author":"W Ouyang","year":"2008","unstructured":"Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity. 2008;28:454\u201367.","journal-title":"Immunity"},{"key":"2058_CR14","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3109\/15412555.2013.770456","volume":"10","author":"L Zhang","year":"2013","unstructured":"Zhang L, Cheng Z, Liu W, Wu K. Expression of interleukin (IL)-10, IL-17A and IL-22 in serum and sputum of stable chronic obstructive pulmonary disease patients. COPD. 2013;10:459\u201365.","journal-title":"COPD"},{"key":"2058_CR15","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/j.1365-2249.2009.03965.x","volume":"157","author":"A Di Stefano","year":"2009","unstructured":"Di Stefano A, Caramori G, Gnemmi I, Contoli M, Vicari C, Capelli A, Magno F, D\u2019Anna SE, Zanini A, Brun P, et al. T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients. Clin Exp Immunol. 2009;157:316\u201324.","journal-title":"Clin Exp Immunol"},{"key":"2058_CR16","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1016\/j.rmed.2011.05.017","volume":"105","author":"MI Vargas-Rojas","year":"2011","unstructured":"Vargas-Rojas MI, Ramirez-Venegas A, Limon-Camacho L, Ochoa L, Hernandez-Zenteno R, Sansores RH. Increase of Th17 cells in peripheral blood of patients with chronic obstructive pulmonary disease. Respir Med. 2011;105:1648\u201354.","journal-title":"Respir Med"},{"key":"2058_CR17","unstructured":"The global initiative for chronic obstructive lung disease. GOLD 2017 global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease 2017 report [EB\/OL]. (2016\u201311\u201316) [2017\u201301\u201303]. http:\/\/www.goldcopd.org."},{"key":"2058_CR18","doi-asserted-by":"publisher","first-page":"15063","DOI":"10.1038\/npjpcrm.2015.63","volume":"25","author":"WC Huang","year":"2015","unstructured":"Huang WC, Wu MF, Chen HC, Hsu JY, Group T. Features of COPD patients by comparing CAT with mMRC: a retrospective, cross-sectional study. NPJ Prim Care Respir Med. 2015;25:15063.","journal-title":"NPJ Prim Care Respir Med"},{"key":"2058_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/0471142956.cy0635s71","volume":"71","author":"F Karlsson","year":"2015","unstructured":"Karlsson F, Hassan-Zahraee M. Quantification of Th1 and Th17 cells with intracellular staining following PMA\/ionomycin stimulation. Curr Protoc Cytom. 2015;71:35\u20137. https:\/\/doi.org\/10.1002\/0471142956.cy0635s71.","journal-title":"Curr Protoc Cytom"},{"key":"2058_CR20","doi-asserted-by":"crossref","unstructured":"Ruhle PF, Fietkau R, Gaipl US, Frey B. Development of a modular assay for detailed immunophenotyping of peripheral human whole blood samples by multicolor flow cytometry. Int J Mol Sci. 2016; 17.","DOI":"10.3390\/ijms17081316"},{"key":"2058_CR21","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/ni1467","volume":"8","author":"EV Acosta-Rodriguez","year":"2007","unstructured":"Acosta-Rodriguez EV, Rivino L, Geginat J, Jarrossay D, Gattorno M, Lanzavecchia A, Sallusto F, Napolitani G. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol. 2007;8:639\u201346.","journal-title":"Nat Immunol"},{"key":"2058_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/imm.13059","volume":"157","author":"QP Nguyen","year":"2019","unstructured":"Nguyen QP, Deng TZ, Witherden DA, Goldrath AW. Origins of CD4(+) circulating and tissue-resident memory T-cells. Immunology. 2019;157:3\u201312.","journal-title":"Immunology"},{"key":"2058_CR23","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12674","volume":"88","author":"J Sun","year":"2018","unstructured":"Sun J, Liu T, Yan Y, Huo K, Zhang W, Liu H, Shi Z. The role of Th1\/Th2 cytokines played in regulation of specific CD4 (+) Th1 cell conversion and activation during inflammatory reaction of chronic obstructive pulmonary disease. Scand J Immunol. 2018;88: e12674.","journal-title":"Scand J Immunol"},{"key":"2058_CR24","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1177\/039463200902200413","volume":"22","author":"A Amedei","year":"2009","unstructured":"Amedei A, Della Bella C, Niccolai E, Stanflin N, Benagiano M, Duranti R, Del Prete G, Murphy TF, D\u2019Elios MM. Moraxella catarrhalis-specific Th1 cells in BAL fluids of chronic obstructive pulmonary disease patients. Int J Immunopathol Pharmacol. 2009;22:979\u201390.","journal-title":"Int J Immunopathol Pharmacol"},{"key":"2058_CR25","doi-asserted-by":"publisher","first-page":"753","DOI":"10.3389\/fimmu.2017.00753","volume":"8","author":"G Arellano","year":"2017","unstructured":"Arellano G, Acuna E, Reyes LI, Ottum PA, De Sarno P, Villarroel L, Ciampi E, Uribe-San Martin R, Carcamo C, Naves R. Th1 and Th17 cells and associated cytokines discriminate among clinically isolated syndrome and multiple sclerosis phenotypes. Front Immunol. 2017;8:753.","journal-title":"Front Immunol"},{"key":"2058_CR26","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/ni.3202","volume":"16","author":"M Bruchard","year":"2015","unstructured":"Bruchard M, Rebe C, Derangere V, Togbe D, Ryffel B, Boidot R, Humblin E, Hamman A, Chalmin F, Berger H, et al. The receptor NLRP3 is a transcriptional regulator of TH2 differentiation. Nat Immunol. 2015;16:859\u201370.","journal-title":"Nat Immunol"},{"key":"2058_CR27","doi-asserted-by":"publisher","first-page":"3890","DOI":"10.1177\/0300060518781642","volume":"46","author":"B Wei","year":"2018","unstructured":"Wei B, Sheng Li C. Changes in Th1\/Th2-producing cytokines during acute exacerbation chronic obstructive pulmonary disease. J Int Med Res. 2018;46:3890\u2013902.","journal-title":"J Int Med Res"},{"key":"2058_CR28","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1111\/cea.12970","volume":"47","author":"K Hirai","year":"2017","unstructured":"Hirai K, Shirai T, Suzuki M, Akamatsu T, Suzuki T, Hayashi I, Yamamoto A, Akita T, Morita S, Asada K, et al. A clustering approach to identify and characterize the asthma and chronic obstructive pulmonary disease overlap phenotype. Clin Exp Allergy. 2017;47:1374\u201382.","journal-title":"Clin Exp Allergy"},{"key":"2058_CR29","first-page":"4427","volume":"24","author":"L Yang","year":"2018","unstructured":"Yang L, Ou Y. Study on the role of DCs, Th1 and Th2 cells in the immune mechanism of COPD. J Med Recapitul. 2018;24:4427\u201332.","journal-title":"J Med Recapitul"},{"key":"2058_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111044","volume":"9","author":"Y Jin","year":"2014","unstructured":"Jin Y, Wan Y, Chen G, Chen L, Zhang MQ, Deng L, Zhang JC, Xiong XZ, Xin JB. Treg\/IL-17 ratio and Treg differentiation in patients with COPD. PLoS ONE. 2014;9: e111044.","journal-title":"PLoS ONE"},{"key":"2058_CR31","doi-asserted-by":"publisher","first-page":"4ra10","DOI":"10.1126\/scitranlsmed.3000154","volume":"1","author":"M Shan","year":"2009","unstructured":"Shan M, Cheng HF, Song LZ, Roberts L, Green L, Hacken-Bitar J, Huh J, Bakaeen F, Coxson HO, Storness-Bliss C, et al. Lung myeloid dendritic cells coordinately induce TH1 and TH17 responses in human emphysema. Sci Transl Med. 2009;1:4ra10.","journal-title":"Sci Transl Med"},{"key":"2058_CR32","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1080\/15412555.2017.1385055","volume":"14","author":"X Yang","year":"2017","unstructured":"Yang X, Huo B, Zhong X, Su W, Liu W, Li Y, He Z, Bai J. Imbalance between subpopulations of regulatory T cells in patients with acute exacerbation of COPD. COPD. 2017;14:618\u201325.","journal-title":"COPD"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-022-02058-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-022-02058-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-022-02058-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T09:03:21Z","timestamp":1653728601000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-022-02058-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,28]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2058"],"URL":"https:\/\/doi.org\/10.1186\/s12931-022-02058-x","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,28]]},"assertion":[{"value":"20 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed at West China Hospital of Sichuan University. The study was approved by the institutional ethics committees of West China Hospital of Sichuan University (identification no. 2018[283]), and it has been registered in the China Clinical Trials Registry on September 19, 2018 (ChiCTR1800018452). All the participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"137"}}